United Therapeutics could eventually use the genetically edited swine to grow organs for human transplant recipients. A ...

Silver Spring’s United Therapeutics has scored a regulatory green light to start clinical trials for its genetically modified pig kidneys to be transplanted into humans. It's as significant for the ...

United Therapeutics UTHR has outperformed the market over the past 20 years by 6.47% on an annualized basis producing an average annual return of 14.94%. Currently, United Therapeutics has a ...

United Therapeutics’ organ and organ alternative manufacturing efforts consist of four platforms – xenotransplantation, regenerative medicine, 3D organ bioprinting, and bio-artificial organs ...